Trial NCT02792192

View at ClinicalTrials.gov 
Org. Study IDs: WO29635

Last trial update was posted on 2021-10-28

MeSH Interventions

Atezolizumab

MeSH Conditions

Non-Muscle Invasive Bladder Neoplasms Urinary Bladder Neoplasms

Other Conditions

Bladder Cancer

Stopping Reasons

The study was terminated early as the study had met its goals of providing preliminary safety and efficacy information for atezolizumab monotherapy alone and in combination with BCG in NMIBC.

Limitations And Caveats

Participants were enrolled only in Cohort 1 of this study. The Sponsor decided not to enroll participants in Cohorts 2 and 3 after the enrollment of 24 patients in Cohort 1 (BCG-unresponsive cohort), as the study had met its goals of providing preliminary safety and efficacy information for atezolizumab monotherapy alone and in combination with BCG in NMIBC.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID